|
Press Releases |
|
 |
|
Wednesday, December 20, 2023 |
|
欧康维视生物: OT-703获批于香港上市,为糖尿病性黄斑水肿患者治疗带来新选择 |
中国领先眼科医药平台公司 — 欧康维视生物(「欧康维视」或「公司」,连同其附属公司,统称「集团」,股份代号:1477)欣然宣布,集团旗下OT-703(ILUVIEN(R),氟轻松玻璃体植入剂) more info >> |
|
歐康維視生物: OT-703獲批於香港上市,為糖尿病性黃斑水腫患者治療帶來新選擇 |
中國領先眼科醫藥平台公司 — 歐康維視生物(「歐康維視」或「公司」,連同其附屬公司,統稱「集團」,股份代號:1477)欣然宣佈,集團旗下OT-703(ILUVIEN(R),氟輕鬆玻璃體植入劑) more info >> |
|
Ocumension Therapeutics: The Approval Received For Marketing OT-703 In Hong Kong, A New Option For Patients With Diabetic Macular Edema |
Ocumension Therapeutics ("Ocumension" or the "Company", together with its subsidiaries, collectively the "Group", stock code: 1477), a leading China ophthalmic pharmaceutical platform company, is pleased to announce that, OT-703 (ILUVIEN(R), fluocinolone intravitreal implant), an injectable more info >> |
|
Thursday, August 24, 2023 |
|
欧康维视公布2023年中期业绩 |
中国领先眼科医药平台公司 — 欧康维视生物 (「欧康维视」或「公司」,连同其附属公司,统称「集团」)(股份代号:1477.HK),今天公布截至2023年6月30日止六个月(「报告期内」)中期业绩。 more info >> |
|
歐康維視公佈2023年中期業績 |
中國領先眼科醫藥平台公司 — 歐康維視生物 (「歐康維視」或「公司」,連同其附屬公司,統稱「集團」)(股份代號:1477.HK),今天公佈截至2023年6月30日止六個月(「報告期內」)中期業績。 more info >> |
|
Ocumension Therapeutics Announces 2023 Interim Results |
Ocumension Therapeutics ("Ocumension" or the "Company", together with its subsidiaries, collectively the "Group", stock code: 1477), a leading China ophthalmic pharmaceutical platform company, announced its interim results for the six months ended 30 June 2023 ("the Period") today. more info >> |
|
Thursday, March 30, 2023 |
|
欧康维视公布2022年全年业绩 |
中国领先眼科医药平台公司 — 欧康维视生物 (「欧康维视」或「公司」,连同其附属公司,统称「集团」)(股份代号:1477.HK),今天公布截至2022年12月31日止年度(「年度」)全年业绩。 more info >> |
|
歐康維視公佈2022年全年業績 |
中國領先眼科醫藥平台公司 — 歐康維視生物 (「歐康維視」或「公司」,連同其附屬公司,統稱「集團」)(股份代號:1477.HK),今天公佈截至2022年12月31日止年度(「年度」)全年業績。 more info >> |
|
Ocumension Therapeutics Announces 2022 Annual Results |
Ocumension Therapeutics ("Ocumension" or the "Company", together with its subsidiaries, collectively the "Group", stock code: 1477), a leading China ophthalmic pharmaceutical platform company, announced its annual results for the year ended 31 December 2022 today. more info >> |
|
Monday, March 13, 2023 |
|
欧康维视获纳入沪港通及深港通名单 |
中国领先眼科医药平台公司 — 欧康维视生物(「欧康维视」或「公司」,连同其附属公司,统称「集团」,股份代号:1477)欣然宣布,集团在香港联合交易所有限公司(「香港交易所」)发行的普通股正式被纳入港股通下沪港通及深港通股票名单,并于3月13日起生效。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Everest Medicines Announces Approval of 'B' Marker Removal from Company's Stock Code by the Hong Kong Stock Exchange
Apr 23, 2025 09:09 HKT/SGT
|
|
|
Earth Day Special: foundit Report Reveals 27% Surge in Green Jobs as Singapore Accelerates Sustainability Push
Apr 23, 2025 09:00 HKT/SGT
|
|
|
CIRC: Attained a New High in Fiscal Year 2024
Apr 23, 2025 08:57 HKT/SGT
|
|
|
2025 U.S. Open Polo Championship Final Concludes American High-Goal Season, Supported by U.S. Polo Assn.
Apr 22, 2025 22:41 HKT/SGT
|
|
|
2025年美國高水準馬球賽季圓滿落幕-美國馬球協會鼎力支持的U.S. Open馬球錦標賽總決賽
Apr 22, 2025 19:00 HKT/SGT
|
|
|
2025年美国高水平马球赛季圆满落幕——美国马球协会鼎力支持的U.S. Open马球锦标赛总决赛
Apr 22, 2025 19:00 HKT/SGT
|
|
|
A Strategic Event for HR Leaders and Experts to Drive Transformation in the Saudi Workforce
Apr 22, 2025 16:40 HKT/SGT
|
|
|
New Trading Bot Pivozon Targets Gold Traders Using Hourly Chart Strategies
Apr 22, 2025 16:00: JST
|
|
|
Under the patronage of Maktoum bin Mohammed DIFC to host 3rd edition of Dubai FinTech Summit on 12-13 May 2025
Apr 22, 2025 16:00 HKT/SGT
|
|
|
New Trading Bot Pivozon Targets Gold Traders Using Hourly Chart Strategies
Apr 22, 2025 15:30 HKT/SGT
|
|
|
Meerkat ($MERK) introduces utility-focused meme ecosystem with staking, gaming, and AI features
Apr 22, 2025 12:00: JST
|
|
|
A Decade of Olympus India's Commitment to Community Welfare
Apr 22, 2025 13:00 JST
|
|
|
Meerkat ($MERK) introduces utility-focused meme ecosystem with staking, gaming, and AI features
Apr 22, 2025 11:00 HKT/SGT
|
|
|
富士通と理研、世界最大級の256量子ビットの超伝導量子コンピュータを開発
Apr 22, 2025 11:00: JST
|
|
|
北京能源國際2024年業績:戰略韌性築基 創新效能引領綠色增長新範式
Apr 22, 2025 10:49 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|